发布求助
文献互助 智能选刊 最新文献

Italian Journal of Dermatology and Venereology最新文献

筛选
英文 中文
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases. 皮肤病患者接种带状疱疹疫苗：意大利 SIDeMaST 性传播疾病、传染病和热带病小组的立场声明。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-23 DOI: 10.23736/S2784-8671.24.07895-2
Giulia Ciccarese, Francesco Drago, Astrid Herzum, Laura Atzori, Annunziata Dattola, Marco Galluzzo, Carlo Maronese, Annalisa Patrizi, Bianca M Piraccini, Sebastiano Recalcati, Maria C Fargnoli, Angelo V Marzano, Manuela Papini
{"title":"Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases.","authors":"Giulia Ciccarese, Francesco Drago, Astrid Herzum, Laura Atzori, Annunziata Dattola, Marco Galluzzo, Carlo Maronese, Annalisa Patrizi, Bianca M Piraccini, Sebastiano Recalcati, Maria C Fargnoli, Angelo V Marzano, Manuela Papini","doi":"10.23736/S2784-8671.24.07895-2","DOIUrl":"10.23736/S2784-8671.24.07895-2","url":null,"abstract":"<p><p>Herpes zoster (HZ) is a condition caused by the reactivation of varicella-zoster virus (VZV), the virus responsible for chickepox, which is the clinical manifestation of the primary infection. Congenital or acquired immune system deficiencies, as well as the physiological decline in immune response occurring in the elderly, known as immune senescence, can allow VZV reactivation and, consequently, HZ. One out of 3 people develops HZ during their lifetime. Moreover, thirty percent of the affected subjects develop post-herpetic neuralgia, the most frequent complication after HZ skin rash. Patients with dermatological conditions characterized by alteration of the immune system, such as systemic lupus erythematosus, psoriasis, atopic dermatitis, bullous diseases, and cutaneous lymphomas, are at higher risk of developing HZ and post-herpetic neuralgia, even when their disease is in remission. In the present work, we described the currently available vaccinations against HZ and provided recommendations for the vaccination against HZ in patients with dermatological diseases.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"375-379"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of cutaneous nodular amyloidosis in an adolescent patient. 一例青少年皮肤结节性淀粉样变性病。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-02 DOI: 10.23736/S2784-8671.24.07801-0
Giulia Calabrese, Vittorio Tancredi, Alina DE Rosa, Caterina M Giorgio, Gaetano Licata
{"title":"A case of cutaneous nodular amyloidosis in an adolescent patient.","authors":"Giulia Calabrese, Vittorio Tancredi, Alina DE Rosa, Caterina M Giorgio, Gaetano Licata","doi":"10.23736/S2784-8671.24.07801-0","DOIUrl":"10.23736/S2784-8671.24.07801-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"462-463"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basal cell carcinoma of the scalp: surgical approach and reconstructive options. 头皮基底细胞癌：手术方法和重建方案。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-27 DOI: 10.23736/S2784-8671.24.07764-8
Giorgio Raposio, Alessandro Gualdi, Ilaria Baldelli, Edoardo Raposio
{"title":"Basal cell carcinoma of the scalp: surgical approach and reconstructive options.","authors":"Giorgio Raposio, Alessandro Gualdi, Ilaria Baldelli, Edoardo Raposio","doi":"10.23736/S2784-8671.24.07764-8","DOIUrl":"10.23736/S2784-8671.24.07764-8","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical therapy of basal cell carcinomas (BCC) is based on complete excision of the neoplasm and its immediate suitable reconstruction. The aim of this work was to evaluate the possibility of creating a reconstructive algorithm in cases of scalp BCC, depending on the amplitude of the tumor.</p><p><strong>Evidence acquisition: </strong>A literature search was carried out using the databases of PubMed, Scopus and Cochrane.</p><p><strong>Evidence synthesis: </strong>Based on the experiences reported in the literature, it was possible to structure a decision-making algorithm that summarizes the various steps involved in the choice of the most suitable reconstructive surgical therapy.</p><p><strong>Conclusions: </strong>The algorithm described we hope will be of reference or help to less experienced reconstructive plastic surgeons.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"412-416"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Janus kinase inhibitors for alopecia areata: a comprehensive review. 探索治疗斑秃的 Janus 激酶抑制剂：综述。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-23 DOI: 10.23736/S2784-8671.24.07894-0
Randa Bushwereb, Gautam Srivastava
{"title":"Exploring Janus kinase inhibitors for alopecia areata: a comprehensive review.","authors":"Randa Bushwereb, Gautam Srivastava","doi":"10.23736/S2784-8671.24.07894-0","DOIUrl":"10.23736/S2784-8671.24.07894-0","url":null,"abstract":"<p><strong>Introduction: </strong>Alopecia areata poses a significant challenge due to its chronic autoimmune nature, leading to psychosocial impacts. Recent strides in understanding the disease have spotlighted Janus kinase (JAK) inhibitors as potential therapies. This comprehensive review aims to assess Baricitinib's efficacy and safety in treating scalp, eyebrow, and eyelash alopecia areata, and compare the effectiveness of Ritlecitinib and Brepocitinib.</p><p><strong>Evidence acquisition: </strong>Conducting a thorough electronic literature search, we focused on clinical studies of JAK inhibitors for moderate to severe alopecia areata from 2015 onward. Key databases, including MEDLINE, PubMed, Cochrane Library, EMBASE, Google Scholar, and Medscape, were utilized. Primary outcomes included changes in the Severity of Alopecia Tool (SALT) score, with safety data evaluating adverse events and serious adverse events. The risk of bias was assessed using the Cochrane Risk of Bias Tool.</p><p><strong>Evidence synthesis: </strong>Among the twelve studies identified, Baricitinib demonstrated superior efficacy over placebo at 24 weeks, with both 2mg and 4mg dosages significantly reducing SALT scores. Comparative efficacy at 24 weeks for Baricitinib, Brepocitinib, and Ritlecitinib showed similar effectiveness compared to placebo, with a marginal superiority observed for Baricitinib 4mg. All JAK inhibitors were well-tolerated, with reported adverse events primarily being mild and manageable.</p><p><strong>Conclusions: </strong>Collectively, the reviewed studies affirm JAK inhibitors, particularly Baricitinib, as promising treatments for moderate to severe alopecia areata. These inhibitors exhibit superior efficacy, as indicated by notable reductions in SALT scores, and are well-tolerated, with predominantly mild and manageable adverse events.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"380-389"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: time to draw up treatment guidelines? 小儿史蒂文斯-约翰逊综合征/毒性表皮坏死症重叠；是时候制定治疗指南了吗？
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-23 DOI: 10.23736/S2784-8671.24.07892-7
Alessandra Gelmetti, Alessandro Pileri, Fabio Caramelli, Marco A Chessa, Cosimo Misciali, Bianca M Piraccini, Iria Neri
{"title":"Pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: time to draw up treatment guidelines?","authors":"Alessandra Gelmetti, Alessandro Pileri, Fabio Caramelli, Marco A Chessa, Cosimo Misciali, Bianca M Piraccini, Iria Neri","doi":"10.23736/S2784-8671.24.07892-7","DOIUrl":"10.23736/S2784-8671.24.07892-7","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"466-467"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eruptive blue nevi of the scalp mimicking melanoma metastases. 模仿黑色素瘤转移的头皮爆发性蓝痣。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-06-17 DOI: 10.23736/S2784-8671.24.07719-3
Federica Li Pomi, Laura Macca, Mario Vaccaro, Maria Lentini, Francesco Borgia
{"title":"Eruptive blue nevi of the scalp mimicking melanoma metastases.","authors":"Federica Li Pomi, Laura Macca, Mario Vaccaro, Maria Lentini, Francesco Borgia","doi":"10.23736/S2784-8671.24.07719-3","DOIUrl":"10.23736/S2784-8671.24.07719-3","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"472-473"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the effect of adapalene 0.3%/benzoyl peroxide 2.5% gel in Korean patients with acne: a randomized, double-blind clinical trial, with a histopathological and immunohistochemical study. 韩国痤疮患者使用阿达帕林 0.3%/过氧化苯甲酰 2.5% 凝胶的效果研究：随机双盲临床试验，以及组织病理学和免疫组化研究。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 DOI: 10.23736/S2784-8671.24.07800-9
Jun-Hyo Lee, Dong-Hyo Kim, Ji-Young Yoon, Tae-Min Kim, Seong-Rae Kim, Dae-Hun Suh
{"title":"Investigation of the effect of adapalene 0.3%/benzoyl peroxide 2.5% gel in Korean patients with acne: a randomized, double-blind clinical trial, with a histopathological and immunohistochemical study.","authors":"Jun-Hyo Lee, Dong-Hyo Kim, Ji-Young Yoon, Tae-Min Kim, Seong-Rae Kim, Dae-Hun Suh","doi":"10.23736/S2784-8671.24.07800-9","DOIUrl":"10.23736/S2784-8671.24.07800-9","url":null,"abstract":"<p><strong>Background: </strong>Acne vulgaris poses significant physical and psychological challenges worldwide. Data of adapalene 0.3%/benzoyl peroxide 2.5% gel (A0.3/BPO2.5) for acne treatment in Asian patients is limited.</p><p><strong>Methods: </strong>In this randomized double-blind clinical trial, 49 Korean patients with moderate-to-severe acne and scars were assigned to the A0.3/BPO2.5 (N.=37) or vehicle (N.=12) group. Acne and acne scar severity scores were assessed at baseline and 4, 8, 12, and 24 weeks. The primary outcomes were treatment success rate (reduction of ≥2 Investigator's Global Assessment grade and reaching a grade of 0 or 1) and proportional acne lesion and scar count reduction against the baseline. To assess histological changes, 2-mm punch biopsies were performed at baseline and week 24 on the respective inflammatory lesions or scars.</p><p><strong>Results: </strong>At week 24, the A0.3/BPO2.5 group had a significantly higher treatment success rate than the vehicle group. The total acne count, inflammatory lesion count, and non-inflammatory lesion count percentages (against baselines) with A0.3/BPO2.5 and the vehicle were 12.1% vs. 96.7%, 8.0% vs. 101.2%, and 13.3% vs. 98.9%, respectively (all P<0.001). Scar count percentages (against baselines) with A0.3/BPO2.5 and the vehicle were 27.3% and 96.5%, respectively (P<0.001). Significant elevations in collagen 1 and 3, elastin, CK15, and p63 levels, with increases of 172.7%, 230.6%, 176.5%, 286.2%, and 105.9%, respectively, in comparison to baseline (all P<0.05). No major adverse events leading to discontinuation were observed.</p><p><strong>Conclusions: </strong>A0.3/BPO2.5 was an effective and safe treatment for acne and acne scars in Asian patients supported by robust histopathological and immunohistochemical evidence.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":"159 4","pages":"444-452"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis. 古舍库单抗在确诊为关节炎的银屑病关节炎和疾病进展中的作用。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-06-03 DOI: 10.23736/S2784-8671.24.07921-0
Annunziata Dattola, Nicoletta Bernardini, Jasmine Anedda, Laura Atzori, Claudio Bonifati, Pier L Bruni, Dario Graceffa, Domenico Giordano, Elisa Molinelli, Gaia Moretta, Cristina Mugheddu, Annamaria Offidani, Gianluca Pagnanelli, Sabatino Pallotta, Manuela Papini, Severino Persechino, Antonio G Richetta, Ersilia Tolino, Giovanni Pellacani, Concetta Potenza
{"title":"The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.","authors":"Annunziata Dattola, Nicoletta Bernardini, Jasmine Anedda, Laura Atzori, Claudio Bonifati, Pier L Bruni, Dario Graceffa, Domenico Giordano, Elisa Molinelli, Gaia Moretta, Cristina Mugheddu, Annamaria Offidani, Gianluca Pagnanelli, Sabatino Pallotta, Manuela Papini, Severino Persechino, Antonio G Richetta, Ersilia Tolino, Giovanni Pellacani, Concetta Potenza","doi":"10.23736/S2784-8671.24.07921-0","DOIUrl":"10.23736/S2784-8671.24.07921-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"467-469"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic management of infantile digital fibromatosis. 婴儿数字纤维瘤病的治疗管理。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-02 DOI: 10.23736/S2784-8671.24.07776-4
Vincenzo Greco, Maria C Annunziata, Massimiliano Scalvenzi, Luca Costanzo, Giuseppe Lauletta, Antonio Portarapillo
{"title":"Therapeutic management of infantile digital fibromatosis.","authors":"Vincenzo Greco, Maria C Annunziata, Massimiliano Scalvenzi, Luca Costanzo, Giuseppe Lauletta, Antonio Portarapillo","doi":"10.23736/S2784-8671.24.07776-4","DOIUrl":"10.23736/S2784-8671.24.07776-4","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"459-460"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful therapy of refractory cutaneous morphea with tofacitinib. 托法替尼成功治疗了难治性皮肤斑秃。
IF 1.8 4区 医学
Italian Journal of Dermatology and Venereology Pub Date : 2024-08-01 Epub Date: 2024-05-23 DOI: 10.23736/S2784-8671.24.07925-8
Giuseppe Russo, Shireen Dumont, Emmanuel Laffitte
{"title":"Successful therapy of refractory cutaneous morphea with tofacitinib.","authors":"Giuseppe Russo, Shireen Dumont, Emmanuel Laffitte","doi":"10.23736/S2784-8671.24.07925-8","DOIUrl":"10.23736/S2784-8671.24.07925-8","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":"469-470"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信